Literature DB >> 19563512

Doppler-defined pulmonary hypertension and the risk of death in children with sickle cell disease followed for a mean of three years.

Margaret T Lee1, Tania Small, Muhammad A Khan, Erika B Rosenzweig, Robyn J Barst, Gary M Brittenham.   

Abstract

Pulmonary hypertension (PH) is associated with increased mortality in adults with sickle cell disease (SCD), but its prognostic significance in children is unknown. Eighty-eight children with SCD were followed after echocardiographic screening for PH. After a mean follow-up of 3 years, all 18 subjects with PH were alive. In our children, as in adults with SCD, PH was associated with increased haemolysis. In contrast, our subjects with PH did not have overt systemic disease observed in adults. PH may be a manifestation of progressive organ damage from chronic haemolysis and systemic vasculopathy that ultimately leads to early death in adulthood.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19563512      PMCID: PMC3078564          DOI: 10.1111/j.1365-2141.2009.07779.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  15 in total

1.  Regular transfusion lowers plasma free hemoglobin in children with sickle-cell disease at risk for stroke.

Authors:  Nelson E Lezcano; Nadine Odo; Abdullah Kutlar; Donald Brambilla; Robert J Adams
Journal:  Stroke       Date:  2006-04-20       Impact factor: 7.914

2.  Cerebrovascular disease associated with sickle cell pulmonary hypertension.

Authors:  Gregory J Kato; Matthew Hsieh; Roberto Machado; James Taylor; Jane Little; John A Butman; Tanya Lehky; John Tisdale; Mark T Gladwin
Journal:  Am J Hematol       Date:  2006-07       Impact factor: 10.047

3.  Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes.

Authors:  Laura M De Castro; Jude C Jonassaint; Felicia L Graham; Allison Ashley-Koch; Marilyn J Telen
Journal:  Am J Hematol       Date:  2008-01       Impact factor: 10.047

4.  Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.

Authors:  Gregory J Kato; Vicki McGowan; Roberto F Machado; Jane A Little; James Taylor; Claudia R Morris; James S Nichols; Xunde Wang; Mirjana Poljakovic; Sidney M Morris; Mark T Gladwin
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

5.  Pulmonary hypertension in patients with sickle cell disease: a longitudinal study.

Authors:  Kenneth I Ataga; Charity G Moore; Susan Jones; Oludamilola Olajide; Dell Strayhorn; Alan Hinderliter; Eugene P Orringer
Journal:  Br J Haematol       Date:  2006-07       Impact factor: 6.998

Review 6.  Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension.

Authors:  Roberto F Machado; Mark T Gladwin
Journal:  Br J Haematol       Date:  2005-05       Impact factor: 6.998

Review 7.  Pulmonary hypertension in sickle cell disease: relevance to children.

Authors:  Gregory J Kato; Onyinye C Onyekwere; Mark T Gladwin
Journal:  Pediatr Hematol Oncol       Date:  2007 Apr-May       Impact factor: 1.969

8.  Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation.

Authors:  Caterina P Minniti; Craig Sable; Andrew Campbell; Sohail Rana; Gregory Ensing; Niti Dham; Onyinye Onyekwere; Mehdi Nouraie; Gregory J Kato; Mark T Gladwin; Oswaldo L Castro; Victor R Gordeuk
Journal:  Haematologica       Date:  2009-02-11       Impact factor: 9.941

9.  Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency.

Authors:  Victor R Gordeuk; Vandana Sachdev; James G Taylor; Mark T Gladwin; Gregory Kato; Oswaldo L Castro
Journal:  Am J Hematol       Date:  2008-01       Impact factor: 10.047

10.  Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

Authors:  Mark T Gladwin; Vandana Sachdev; Maria L Jison; Yukitaka Shizukuda; Jonathan F Plehn; Karin Minter; Bernice Brown; Wynona A Coles; James S Nichols; Inez Ernst; Lori A Hunter; William C Blackwelder; Alan N Schechter; Griffin P Rodgers; Oswaldo Castro; Frederick P Ognibene
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245

View more
  18 in total

1.  Vascular risk assessment in patients with sickle cell disease.

Authors:  Claudia R Morris
Journal:  Haematologica       Date:  2011-01       Impact factor: 9.941

2.  Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia.

Authors:  Omar Niss; Robert Fleck; Fowe Makue; Tarek Alsaied; Payal Desai; Jeffrey A Towbin; Punam Malik; Michael D Taylor; Charles T Quinn
Journal:  Blood       Date:  2017-05-15       Impact factor: 22.113

Review 3.  Minireview: Clinical severity in sickle cell disease: the challenges of definition and prognostication.

Authors:  Charles T Quinn
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-23

4.  Longitudinal effect of disease-modifying therapy on tricuspid regurgitant velocity in children with sickle cell anemia.

Authors:  Parul Rai; Vijaya M Joshi; Jason F Goldberg; Amber M Yates; Victoria I Okhomina; Rhiannon Penkert; Kenneth I Ataga; Guolian Kang; Jane S Hankins
Journal:  Blood Adv       Date:  2021-01-12

5.  Pulmonary hypertension in lambs transfused with stored blood is prevented by breathing nitric oxide.

Authors:  David M Baron; Binglan Yu; Chong Lei; Aranya Bagchi; Arkadi Beloiartsev; Christopher P Stowell; Andrea U Steinbicker; Rajeev Malhotra; Kenneth D Bloch; Warren M Zapol
Journal:  Anesthesiology       Date:  2012-03       Impact factor: 7.892

6.  Elevated tricuspid regurgitation velocity and decline in exercise capacity over 22 months of follow up in children and adolescents with sickle cell anemia.

Authors:  Victor R Gordeuk; Caterina P Minniti; Mehdi Nouraie; Andrew D Campbell; Sohail R Rana; Lori Luchtman-Jones; Craig Sable; Niti Dham; Gregory Ensing; Josef T Prchal; Gregory J Kato; Mark T Gladwin; Oswaldo L Castro
Journal:  Haematologica       Date:  2010-09-30       Impact factor: 9.941

Review 7.  Sickle cell disease in children.

Authors:  Emily Riehm Meier; Jeffery L Miller
Journal:  Drugs       Date:  2012-05-07       Impact factor: 9.546

8.  The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.

Authors:  Martin H Steinberg; William F McCarthy; Oswaldo Castro; Samir K Ballas; F Danny Armstrong; Wally Smith; Kenneth Ataga; Paul Swerdlow; Abdullah Kutlar; Laura DeCastro; Myron A Waclawiw
Journal:  Am J Hematol       Date:  2010-06       Impact factor: 10.047

Review 9.  Sickle cell disease in childhood: from newborn screening through transition to adult medical care.

Authors:  Charles T Quinn
Journal:  Pediatr Clin North Am       Date:  2013-12       Impact factor: 3.278

10.  Tricuspid regurgitant jet velocity and myocardial tissue Doppler parameters predict mortality in a cohort of patients with sickle cell disease spanning from pediatric to adult age groups - revisiting this controversial concept after 16 years of additional evidence.

Authors:  Payal Shah; Silvie Suriany; Roberta Kato; Adam M Bush; Patjanaporn Chalacheva; Saranya Veluswamy; Christopher C Denton; Kelly Russell; Maha Khaleel; Henry J Forman; Michael C K Khoo; Richard Sposto; Thomas D Coates; John C Wood; Jon Detterich
Journal:  Am J Hematol       Date:  2020-10-12       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.